Aurora Cannabis (TSE:ACB) Stock Price Down 0.8% – Time to Sell?

Aurora Cannabis Inc. (TSE:ACBGet Free Report)’s share price was down 0.8% during mid-day trading on Thursday . The stock traded as low as C$6.26 and last traded at C$6.34. Approximately 62,609 shares changed hands during trading, a decline of 84% from the average daily volume of 389,808 shares. The stock had previously closed at C$6.39.

Wall Street Analyst Weigh In

A number of research analysts have commented on ACB shares. TD Securities raised shares of Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th. ATB Capital cut their price objective on shares of Aurora Cannabis from C$11.00 to C$8.50 in a report on Tuesday, December 17th. Three analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of C$5.85.

Read Our Latest Stock Analysis on ACB

Aurora Cannabis Trading Down 0.8 %

The firm has a market capitalization of C$346.54 million, a PE ratio of -10.06 and a beta of 2.71. The company has a quick ratio of 2.48, a current ratio of 3.76 and a debt-to-equity ratio of 16.95. The company’s 50-day simple moving average is C$6.42 and its 200 day simple moving average is C$7.38.

About Aurora Cannabis

(Get Free Report)

Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.

Read More

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.